The three-gene KRAS-Macrophage Prognostic Associated Gene (KMPAG) signature, encompassing CLEC4A, CXCL10, and LAT2, emerges as a robust prognostic tool that correlates with distinct clinical and immunological phenotypes in melanoma cohorts. The gene discussed is KRAS; the disease is melanoma.